BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28283395)

  • 1. Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome components among young adult females.
    Hasan H; Attlee A; Raigangar V; Madkour M; Awadallah S
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S337-S341. PubMed ID: 28283395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Plasma Proprotein Convertase Subtilisin/Kexin Type 9 and the Presence of Metabolic Syndrome in a Predominantly Rural-Based Sub-Saharan African Population.
    Paquette M; Luna Saavedra YG; Chamberland A; Prat A; Christensen DL; Lajeunesse-Trempe F; Kaduka L; Seidah NG; Dufour R; Baass A
    Metab Syndr Relat Disord; 2017 Oct; 15(8):423-429. PubMed ID: 28749722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waist circumference is a major determinant of oxidative stress in subjects with and without metabolic syndrome.
    Awadallah S; Hasan H; Attlee A; Raigangar V; Unnikannan H; Madkour M; Abraham MS; Rashid LM
    Diabetes Metab Syndr; 2019; 13(4):2541-2547. PubMed ID: 31405674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia.
    Ferri N; Ruscica M
    Endocrine; 2016 Dec; 54(3):588-601. PubMed ID: 27038318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating PCSK9 concentrations are increased in postmenopausal women with the metabolic syndrome.
    Jeenduang N
    Clin Chim Acta; 2019 Jul; 494():151-156. PubMed ID: 31002780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders.
    Ibarretxe D; Girona J; Plana N; Cabré A; Ferré R; Amigó N; Guaita S; Mallol R; Heras M; Masana L
    Clin Investig Arterioscler; 2016; 28(2):71-8. PubMed ID: 26743379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leptin is associated with metabolic syndrome in obese Mexican subjects.
    García-Jiménez S; Bernal Fernández G; Martínez Salazar MF; Monroy Noyola A; Toledano Jaimes C; Meneses Acosta A; Gonzalez Maya L; Aveleyra Ojeda E; Terrazas Meraz MA; Boll MC; Sánchez-Alemán MA
    J Clin Lab Anal; 2015 Jan; 29(1):5-9. PubMed ID: 24659484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events.
    Ridker PM; Rifai N; Bradwin G; Rose L
    Eur Heart J; 2016 Feb; 37(6):554-60. PubMed ID: 26508163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calorically restricted diets decrease PCSK9 in overweight adolescents.
    Levenson AE; Milliren CE; Biddinger SB; Ebbeling CB; Feldman HA; Ludwig DS; de Ferranti SD
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):342-349. PubMed ID: 28228332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramadan Intermittent Fasting Is Associated with Changes in Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Metabolically Healthy Obese Subjects.
    Hasan H; Madkour M; Awadallah S; Hassanein M; Jahrami H; Faris M
    Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma proprotein convertase subtilisin/kexin type 9 is associated with Lp(a) in type 2 diabetic patients.
    Nekaies Y; Baudin B; Kelbousi S; Sakly M; Attia N
    J Diabetes Complications; 2015; 29(8):1165-70. PubMed ID: 26412029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Proprotein Convertase Subtilisin Kexin Type 9 as a Predictor of Carotid Atherosclerosis in Asymptomatic Adults.
    Chan DC; Pang J; McQuillan BM; Hung J; Beilby JP; Barrett PH; Watts GF
    Heart Lung Circ; 2016 May; 25(5):520-5. PubMed ID: 26706651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sagittal abdominal diameter resembles waist circumference as a surrogate marker of insulin resistance in adolescents-Brazilian Metabolic Syndrome Study.
    da Silva CC; Vasques ACJ; Zambon MP; Camilo DF; De Bernardi Rodrigues AM; Antonio MÂRGM; Geloneze B;
    Pediatr Diabetes; 2018 Aug; 19(5):882-891. PubMed ID: 29573519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male.
    Mansyur MA; Bakri S; Patellongi IJ; Rahman IA
    Clin Nutr ESPEN; 2020 Feb; 35():69-74. PubMed ID: 31987123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study.
    Shi J; Zhang W; Niu Y; Lin N; Li X; Zhang H; Hu R; Ning G; Fan J; Qin L; Su Q; Yang Z
    Cardiovasc Diabetol; 2020 Dec; 19(1):209. PubMed ID: 33302966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk.
    Guardiola M; Plana N; Ibarretxe D; Cabré A; González M; Ribalta J; Masana L
    Clin Sci (Lond); 2015 Jun; 128(12):877-82. PubMed ID: 25649668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical correlations and genetic associations of metabolic syndrome in the United Arab Emirates.
    Osman WM; Khan SM; Jelinek HF; Almahmeed W; Tay GK; Alsafar HS
    Gene; 2020 May; 738():144476. PubMed ID: 32061761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women.
    Levenson AE; Shah AS; Khoury PR; Kimball TR; Urbina EM; de Ferranti SD; Maahs DM; Dolan LM; Wadwa RP; Biddinger SB
    Pediatr Diabetes; 2017 Dec; 18(8):755-760. PubMed ID: 28093849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance of metabolic syndrome and abdominal obesity prevalence according to different criteria in Andean highlanders: A community-based study.
    Herrera-Enriquez K; Narvaez-Guerra O
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S359-S364. PubMed ID: 28284909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.